Impact of Pharmacy Clinic on Diabetes Management (PharmaMD)
PHARM-MD; An Open-Label, Randomized Controlled Phase II Study to Evaluate the Efficacy of a Pharmacist Managed Diabetes Clinic in High-Risk Diabetes Patients
Sponsor: Corewell Health East
This NA trial investigates Diabetes Mellitus, Type 2 and is currently completed. Corewell Health East leads this study, which shows 16 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
16 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Jan 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 11 earlier versions
-
Sep 2021 — Dec 2022 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
May 2020 — Aug 2020 [monthly]
Active Not Recruiting NA
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2019 — Nov 2019 [monthly]
Recruiting NA
-
Nov 2018 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2018 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Corewell Health East
For direct contact, visit the study record on ClinicalTrials.gov .